Advertisement

Neurocritical Care

, Volume 29, Issue 3, pp 385–387 | Cite as

Metabolic Encephalopathy: Behind the Name

  • Eelco F. M. Wijdicks
Neurocritical care through history
  • 405 Downloads

Abstract

Metabolic encephalopathy may be the most common diagnosis in consultative acute neurology. The origin of this term is not generally known but can be traced back. The term replaced more commonly used designations such as organic or functional. The term metabolic encephalopathy was originally linked to organ dysfunction but subsequently became more imprecise. When it expanded to include a large number of diseases, it evolved to “metabolic neuronal dysfunction” and soon could not be distinguished from “quiet delirium” and other designations. This vignette summarizes why the terminology has confused more than clarified but also why it will likely stay in the neurologist’s vernacular.

Keywords

Metabolism Encephalopathy Metabolic neuronal dysfunction Toxic Terminology Delirium 

References

  1. 1.
    Liston EH. Delirium in the aged. Psychiatr Clin North Am. 1982;5:49–66.CrossRefPubMedGoogle Scholar
  2. 2.
    Laureno R. Foundations for clinical neurology. 1st ed. New York: Oxford University Press; 2017.CrossRefGoogle Scholar
  3. 3.
    Eidelman LA, Putterman D, Putterman C, Sprung CL. The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA. 1996;275:470–3.CrossRefPubMedGoogle Scholar
  4. 4.
    Kafa IM, Bakirci S, Uysal M, Kurt MA. Alterations in the brain electrical activity in a rat model of sepsis-associated encephalopathy. Brain Res. 2010;1354:217–26.CrossRefPubMedGoogle Scholar
  5. 5.
    Lockwood AH. Metabolic encephalopathies: opportunities and challenges. J Cereb Blood Flow Metab. 1987;7:523–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Mahoney CA, Arieff AI. Uremic encephalopathies: clinical, biochemical, and experimental features. Am J Kidney Dis. 1982;2:324–36.CrossRefPubMedGoogle Scholar
  7. 7.
    Pun BT, Ely EW. The importance of diagnosing and managing ICU delirium. Chest. 2007;132:624–36.CrossRefPubMedGoogle Scholar
  8. 8.
    Glaser GH. Metabolic encephalopathy in hepatic, renal and pulmonary disorders. Postgrad Med. 1960;27:611–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Fazekas JF. Pathologic physiology of cerebral dysfunction. Am J Med. 1958;25:89–96.CrossRefPubMedGoogle Scholar
  10. 10.
    Fazekas JF, Alman RW. Coma: biochemistry, physiology and therapeutic principles 1st eds. Springfield: Charles C. Thomas Publishers, Ltd.; 1962.Google Scholar
  11. 11.
    Plum F, Posner JB. Diagnosis of Stupor and Coma, vol. 1. Philadelphia: F. A. Davis; 1966.Google Scholar
  12. 12.
    Sherlock S. Pathogenesis and management of hepatic coma. Am J Med. 1958;24:805–13.CrossRefPubMedGoogle Scholar
  13. 13.
    Fugate JE, Kalimullah EA, Hocker SE, Clark SL, Wijdicks EFM, Rabinstein AA. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy. Crit Care. 2013;17:R264.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Wijdicks EFM. Why you may need a neurologist to see a comatose patient in the ICU. Crit Care. 2016;20:193.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2017

Authors and Affiliations

  1. 1.Mayo ClinicDepartment of NeurologyRochesterUSA

Personalised recommendations